EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Effectiveness of nirmatrelvir‐ritonavir on severe outcomes of COVID‐19 in the era of vaccination and Omicron: An updated meta‐analysis

Sien Ombelet iD, Diego Castanares-Zapatero, Fabian Desimpel, Frank Hulstaert, Sabine Stordeur, Dominique Roberfroid

Journal of Medical Virology · 2024-02 · 96 (2)

DOI: 10.1002/jmv.29434 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Medical Virology, online erschienen am 20.02.2024. Verfasst von Sien Ombelet und 5 weiteren Autor:innen. Beteiligte Einrichtung: Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium. Hauptthemen laut MEDLINE: Ritonavir, COVID-19, Lactams, Leucine. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Belgian Health Care Knowledge Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nirmatrelvir‐ritonavir (NR) was approved to treat SARS‐CoV‐2 positive outpatients at high risk of progression to severe disease, based on a randomized trial in unvaccinated patients. Effectiveness in vaccinated patients and against Omicron has not yet been confirmed by clinical trial data, but a recent meta‐analysis suggested good real‐world effectiveness based on 12 studies. We updated this meta‐analysis by searching Medline and Embase databases for studies assessing effectiveness of NR on mortality, hospitalization, composite outcome of hospitalization and/or death, and progression to severe disease, published between October 1, 2022 and May 22, 2023. Random effects meta‐analysis and subgroup analysis for vaccinated patients was performed. A total of 32 studies were included in the meta‐analysis. Pooled RR for the effect of NR on mortality, hospitalization, hospitalization and/or mortality, and progression to severe disease were 0.36 (95% confidence interval [CI]: 0.25−0.52), 0.43 (CI: 0.37−0.51), 0.52 (CI: 0.45−0.61) and 0.54 (CI: 0.41−0.73), respectively. A subgroup analysis on vaccinated patients indicated lower effectiveness of NR on mortality (RR: 0.55, CI: 0.45−0.68), but similar effectiveness for hospitalization, hospitalization and/or mortality, or progression to severe disease (RR: 0.52, 0.58, and 0.66, respectively). This updated meta‐analysis robustly confirms the protective effects of NR on severe COVID‐19 outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RitonavirCOVID-19LactamsLeucineNitrilesProlineHumansCOVID-19 Drug TreatmentSARS-CoV-2VaccinationAntiviral Agents

Stichwörter der Autor:innen

COVID-19PaxlovidSARS-CoV-2meta-analysisnirmatrelvir-ritonavirsystematic review

Substanzen

RitonavirnirmatrelvirAntiviral AgentsLactamsLeucineNitrilesProline

Autor:innen und Institutionen

  • Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.
  • Directorate-General Public Health, Federal Public Service of Health, Food Chain Safety and Environment, Brussels, Belgium.

ORCID-Profile: Sien Ombelet

Förderung

  • Belgian Health Care Knowledge Centre

Zitieren

APA

Ombelet, S., Castanares-Zapatero, D., Desimpel, F., Hulstaert, F., Stordeur, S., & Roberfroid, D. (2024). Effectiveness of nirmatrelvir‐ritonavir on severe outcomes of COVID‐19 in the era of vaccination and Omicron: An updated meta‐analysis. Journal of Medical Virology, 96(2). https://doi.org/10.1002/jmv.29434

Vancouver

Ombelet S, Castanares-Zapatero D, Desimpel F, Hulstaert F, Stordeur S, Roberfroid D. Effectiveness of nirmatrelvir‐ritonavir on severe outcomes of COVID‐19 in the era of vaccination and Omicron: An updated meta‐analysis. Journal of Medical Virology. 2024;96(2). doi:10.1002/jmv.29434

BibTeX
@article{Ombelet2024,
  author = {Ombelet, Sien and Castanares-Zapatero, Diego and Desimpel, Fabian and Hulstaert, Frank and Stordeur, Sabine and Roberfroid, Dominique},
  title = {Effectiveness of nirmatrelvir‐ritonavir on severe outcomes of COVID‐19 in the era of vaccination and Omicron: An updated meta‐analysis},
  journal = {Journal of Medical Virology},
  year = {2024},
  volume = {96},
  number = {2},
  doi = {10.1002/jmv.29434}
}
Kostenlos starten →